A detailed history of Brighton Jones LLC transactions in Dexcom Inc stock. As of the latest transaction made, Brighton Jones LLC holds 4,887 shares of DXCM stock, worth $542,017. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,887
Previous 4,892 0.1%
Holding current value
$542,017
Previous $607,000 11.53%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$114.22 - $140.1 $571 - $700
-5 Reduced 0.1%
4,887 $677,000
Q4 2023

Feb 05, 2024

BUY
$75.49 - $124.16 $2,113 - $3,476
28 Added 0.58%
4,892 $607,000
Q3 2023

Oct 25, 2023

BUY
$86.06 - $137.93 $14,113 - $22,620
164 Added 3.49%
4,864 $453,000
Q2 2023

Jul 31, 2023

BUY
$112.47 - $130.98 $13,046 - $15,193
116 Added 2.53%
4,700 $603,000
Q1 2023

May 08, 2023

BUY
$104.0 - $122.92 $2,392 - $2,827
23 Added 0.5%
4,584 $532,000
Q4 2022

Feb 02, 2023

BUY
$84.98 - $122.67 $4,673 - $6,746
55 Added 1.22%
4,561 $516,000
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $3,893 - $4,803
51 Added 1.14%
4,506 $363,000
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $224,366 - $438,536
3,300 Added 285.71%
4,455 $332,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $188 - $260
-2 Reduced 0.17%
1,155 $591,000
Q4 2021

Feb 03, 2022

SELL
$129.87 - $162.82 $11,168 - $14,002
-86 Reduced 6.92%
1,157 $621,000
Q3 2021

Nov 04, 2021

SELL
$106.71 - $143.18 $14,832 - $19,902
-139 Reduced 10.06%
1,243 $680,000
Q2 2021

Aug 10, 2021

BUY
$80.99 - $107.93 $13,282 - $17,700
164 Added 13.46%
1,382 $590,000
Q1 2021

May 07, 2021

SELL
$84.79 - $104.74 $1,017 - $1,256
-12 Reduced 0.98%
1,218 $438,000
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $9,828 - $13,167
-126 Reduced 9.29%
1,230 $455,000
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $5,062 - $5,986
-53 Reduced 3.76%
1,356 $559,000
Q2 2020

Aug 11, 2020

SELL
$62.68 - $105.34 $13,476 - $22,648
-215 Reduced 13.24%
1,409 $571,000
Q1 2020

May 13, 2020

BUY
$47.79 - $75.63 $11,804 - $18,680
247 Added 17.94%
1,624 $437,000
Q4 2019

Feb 07, 2020

SELL
$36.62 - $57.29 $292 - $458
-8 Reduced 0.58%
1,377 $301,000
Q3 2019

Oct 28, 2019

SELL
$35.53 - $43.8 $355 - $438
-10 Reduced 0.72%
1,385 $207,000
Q2 2019

Aug 05, 2019

BUY
$27.84 - $38.92 $38,836 - $54,293
1,395 New
1,395 $209,000
Q4 2018

Feb 08, 2019

SELL
$26.99 - $37.37 $38,568 - $53,401
-1,429 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$23.35 - $36.72 $33,367 - $52,472
1,429 New
1,429 $204,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $42.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.